Page last updated: 2024-10-29

ifosfamide and Kaposi Sarcoma

ifosfamide has been researched along with Kaposi Sarcoma in 3 studies

Research Excerpts

ExcerptRelevanceReference
"Mucositis is a common toxicity of cancer chemotherapy."6.68Oral glutamine to prevent chemotherapy induced stomatitis: a pilot study. ( Anderson, PM; Skubitz, KM, 1996)
"The most active single agents in soft-tissue sarcomas are doxorubicin (Adriamycin) and ifosfamide, with response rates of 20-35%."4.77Chemotherapy of advanced soft-tissue sarcomas. ( Antman, KH; Elias, AD, 1988)
"Mucositis is a common toxicity of cancer chemotherapy."2.68Oral glutamine to prevent chemotherapy induced stomatitis: a pilot study. ( Anderson, PM; Skubitz, KM, 1996)

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19901 (33.33)18.7374
1990's1 (33.33)18.2507
2000's1 (33.33)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Waddington, TW1
Aboulafia, DM1
Skubitz, KM1
Anderson, PM1
Antman, KH1
Elias, AD1

Reviews

1 review available for ifosfamide and Kaposi Sarcoma

ArticleYear
Chemotherapy of advanced soft-tissue sarcomas.
    Seminars in surgical oncology, 1988, Volume: 4, Issue:1

    Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Dacarbazine; Doxorubicin; Dru

1988

Trials

1 trial available for ifosfamide and Kaposi Sarcoma

ArticleYear
Oral glutamine to prevent chemotherapy induced stomatitis: a pilot study.
    The Journal of laboratory and clinical medicine, 1996, Volume: 127, Issue:2

    Topics: Acquired Immunodeficiency Syndrome; Administration, Oral; Antineoplastic Combined Chemotherapy Proto

1996

Other Studies

1 other study available for ifosfamide and Kaposi Sarcoma

ArticleYear
Failure to eradicate AIDS-associated primary effusion lymphoma with high-dose chemotherapy and autologous stem cell reinfusion: case report and literature review.
    AIDS patient care and STDs, 2004, Volume: 18, Issue:2

    Topics: Acquired Immunodeficiency Syndrome; Antineoplastic Combined Chemotherapy Protocols; Antiretroviral T

2004